• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SHOCKWAVE MEDICAL, INC. SHOCKWAVE C2+ CORONARY INTRAVASCULAR LITHOTRIPSY (IVL) CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SHOCKWAVE MEDICAL, INC. SHOCKWAVE C2+ CORONARY INTRAVASCULAR LITHOTRIPSY (IVL) CATHETER Back to Search Results
Model Number C2PIVL2512
Medical Device Problem Code Material Split, Cut or Torn (4008)
Health Effect - Clinical Code Perforation of Vessels (2135)
Date of Event 06/12/2024
Type of Reportable Event Serious Injury
Event or Problem Description
A shockwave c2+ coronary intravascular lithotripsy (ivl) catheter was used to treat a severely calcified lesion in the right coronary artery (rca).After 50 pulses were delivered, the ivl balloon ruptured and perforated the rca.The physician tried to deliver a papyrus covered stent but was unsuccessful.A 2.25 x 15 balloon was used to occlude the perforation for 60 seconds, and again attempted to deliver a covered stent with a different guide catheter which was unsuccessful.A drug eluding stent (des) was then delivered proximal to the perforation, and the patient was stable at the conclusion of the procedure with a small residual perforation in the mid rca.The patient was transferred to the icu, and then transferred to another hospital.A balloon pump was surgically inserted, and the patient was monitored.Current patient status is unknown.
 
Additional Manufacturer Narrative
The subject device was returned for investigation and inspected.The reported failure of balloon rupture was confirmed.Balloon ruptures are a known failure mode with a low probability of occurrence.Contributing factors include patient calcium, damage caused when the balloon wall comes into close contact with the device emitters, likely causes include (a) an irregular calcium lesion capable of compressing the balloon wall into close proximity with the emitter(s) and/or (b) an incompletely inflated balloon.The patient was noted to have a severely calcified rca.The relationship between the ivl balloon rupture and the reported perforation could not be determined with the information available.This is a known inherent risk with the procedure and the use of the device.The shockwave intravascular lithotripsy (ivl) system with the shockwave c2+ coronary ivl catheter generates acoustic pressure pulses within the target treatment site, disrupting calcium within the lesion allowing subsequent dilatation of a coronary artery stenosis using low balloon pressure not to exceed 4 atm during ivl treatment, and 6 atm for post dilatation.The pressure used for the ivl balloon catheter is much lower than other balloon catheters used in percutaneous coronary intervention (pci), thus the risk associated with loss of balloon pressure during ivl catheter use is negligible.The associated patient risk for this failure mode is low and adequately captured in swmi's risk documentation.The root cause for the subsequent perforation of the patient could not be definitively determined based on the information available.Shockwave medical has controls in place to ensure devices are built to approved procedures and meet lot release acceptance criteria prior to being distributed.A review of the manufacturing and test documentation for subject lot does not reveal any issues with the manufacturing of the device.The device passed all of shockwave medical, inc.Acceptance criteria prior to shipping.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SHOCKWAVE C2+ CORONARY INTRAVASCULAR LITHOTRIPSY (IVL) CATHETER
Common Device Name
SHOCKWAVE C2+ CORONARY INTRAVASCULAR LITHOTRIPSY (IVL) CATHETER
Manufacturer (Section D)
SHOCKWAVE MEDICAL, INC.
5403 betsy ross drive
santa clara CA 95054
Manufacturer (Section G)
SHOCKWAVE MEDICAL, INC.
5403 betsy ross drive
santa clara CA 95054
Manufacturer Contact
alexis weil
5403 betsy ross drive
santa clara, CA 95054
MDR Report Key19726577
Report Number3015053858-2024-00067
Device Sequence Number18175399
Product Code QMG
UDI-Device Identifier00195451000003
UDI-Public(01)00195451000003(17)250930(10)01A230926A
Combination Product (Y/N)N
Initial Reporter StateIL
Initial Reporter CountryUS
PMA/510(K) Number
P200039/S008
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 07/11/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date09/30/2025
Device Model NumberC2PIVL2512
Device Catalogue NumberC2PIVL2512
Device Lot Number01A230926A
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/03/2024
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/12/2024
Initial Report FDA Received Date07/11/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured09/26/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
2.25X15 BALLOON-UNKNOWN MANUFACTURER; DRUG ELUDING STENT-UNKNOWN MANUFACTURER; GUIDE CATHETER-UNKNOWN MANUFACTURER; PAPYRUS COVERED STENT
Outcome Attributed to Adverse Event Other; Hospitalization;
Patient Age79 YR
Patient SexFemale
-
-